R&D represents a significant investment for most companies, but innovation leaders often struggle to accurately measure the output of their R&D activities. The number of new product launches, or revenue generated from products developed through R&D are too simplistic, and can make it difficult to justify investment in long-term R&D projects.

In this webinar we will discuss: 

  • How patent valuation data can be used to measure R&D efficiency
  • Why it makes sense to use an indicator approach to patent valuation
  • Examples of companies who are achieving extremely capital-efficient R&D
  • Other ways that IP value can be used to drive corporate strategy

This webinar is essential viewing for all R&D leaders who are interested in understanding patent valuations and measuring the ROI of their R&D activity.





Dr. Dierk-Oliver Kiehne

Dr. Kiehne is CEO at InTraCoM GmbH, and his research focus is on intellectual property valuation, developing efficient and reliable methodologies.